ArticleInternational journal of genomics2025
Antihypertensive Drugs and Dental Caries Risk: A Drug-Target Mendelian Randomization Analysis.
Article in International journal of genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Genomic Evidence on Antihypertensive Drug Targets and Oral Disease Outcomes.Journal of periodontal research · 2026Article
- Antihypertensive Drugs and Dental Caries Risk: A Drug-Target Mendelian Randomization Analysis.International journal of genomics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and Objectives: To address the clinical uncertainty surrounding the effect of antihypertensive drugs on dental caries, this study was aimed at investigating the causal relationships between antihypertensive medication use and the risk of dental caries, utilizing a drug-target Mendelian randomization (MR) approach. Methods: Nine antihypertensive drug classes' influences on dental caries risk in the UK Biobank and FinnGen populations were assessed using drug-target MR. This genetic method utilizes randomly allocated gene variants as proxies for drug exposure, minimizing the confounding biases inherent in observational studies and allowing for more robust causal inference. Genetic variants associated with systolic blood pressure near the drug target genes were used to proxy for medication effects. Results: In the FinnGen cohort, genetic analysis linked calcium channel blockers to a 3.3% reduction in dental caries risk (OR: 0.967, 95% CI: 0.949-0.985) and loop diuretics to a 6.9% reduction (OR: 0.931, 95% CI: 0.897-0.966). Conversely, aldosterone antagonists were suggestively associated with an 8.2% increased risk (OR: 1.082, 95% CI: 1.017-1.150). Notably, the protective trend for calcium channel blockers and loop diuretics was also observed in the UK Biobank. These findings, validated by eQTLs, highlight the impact of antihypertensive drugs on dental health. Conclusion: The study suggests that calcium channel blockers and diuretics could potentially reduce the risk of dental caries. Additional research is needed to assess the feasibility of repurposing antihypertensive medications for the prevention of dental caries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.